This study suggested that neuroleptic treatment of schizophrenia is strongly associated with hyperprolactinemia and showed important differences between prolactin-sparing and prolactin-elevating medications.
No takes yet. Share an insight, caveat, or question.
Montgomery et al. (2004) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: